Zelira Therapeutics Limited
ZLDAF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $4,871 | $3,965 | $14,807 | $7,969 |
| - Cash | $6 | $586 | $146 | $2,746 |
| + Debt | $2,141 | $5,949 | $438 | $501 |
| Enterprise Value | $7,007 | $9,328 | $15,099 | $5,723 |
| Revenue | $1 | $95 | $301 | $1,541 |
| % Growth | -99.3% | -68.5% | -80.5% | – |
| Gross Profit | -$803 | $10 | -$3,216 | -$5,716 |
| % Margin | -122,400.2% | 10.8% | -1,068% | -371% |
| EBITDA | -$4,051 | -$35,521 | -$6,740 | -$11,886 |
| % Margin | -617,481.4% | -37,409.9% | -2,238.4% | -771.5% |
| Net Income | -$3,628 | -$36,569 | -$5,573 | -$11,945 |
| % Margin | -553,029.3% | -38,513% | -1,850.8% | -775.4% |
| EPS Diluted | -0.32 | -3.22 | -0.55 | -1.49 |
| % Growth | 90.1% | -485.5% | 63.1% | – |
| Operating Cash Flow | -$4,907 | -$4,389 | -$7,249 | -$9,427 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$4,907 | -$4,389 | -$7,249 | -$9,427 |